167 related articles for article (PubMed ID: 28540438)
1. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
Schöttker B; Saum KU; Muhlack DC; Hoppe LK; Holleczek B; Brenner H
Eur J Clin Pharmacol; 2017 Aug; 73(8):1041-1048. PubMed ID: 28540438
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
3. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
4. Association of healthy lifestyle and all-cause mortality according to medication burden.
Kelly NA; Soroka O; Onyebeke C; Pinheiro LC; Banerjee S; Safford MM; Goyal P
J Am Geriatr Soc; 2022 Feb; 70(2):415-428. PubMed ID: 34695226
[TBL] [Abstract][Full Text] [Related]
5. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study.
Saum KU; Schöttker B; Meid AD; Holleczek B; Haefeli WE; Hauer K; Brenner H
J Am Geriatr Soc; 2017 Feb; 65(2):e27-e32. PubMed ID: 28024089
[TBL] [Abstract][Full Text] [Related]
6. The effect of free health care on polypharmacy: a comparison of propensity score methods and multivariable regression to account for confounding.
Richardson K; Kenny RA; Bennett K
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):656-65. PubMed ID: 24677639
[TBL] [Abstract][Full Text] [Related]
7. Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study.
Wimmer BC; Bell JS; Fastbom J; Wiese MD; Johnell K
Ann Pharmacother; 2016 Feb; 50(2):89-95. PubMed ID: 26681444
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy in the Elderly: A Marker of Increased Risk of Mortality in a Population-Based Prospective Study (NEDICES).
Gómez C; Vega-Quiroga S; Bermejo-Pareja F; Medrano MJ; Louis ED; Benito-León J
Gerontology; 2015; 61(4):301-9. PubMed ID: 25502492
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.
Nishtala PS; Salahudeen MS
Gerontology; 2015; 61(3):195-202. PubMed ID: 25428287
[TBL] [Abstract][Full Text] [Related]
10. Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients.
Chen LJ; Nguyen TNM; Chang-Claude J; Hoffmeister M; Brenner H; Schöttker B
Oncologist; 2021 Dec; 26(12):e2170-e2180. PubMed ID: 34476870
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).
Kennel PJ; Kneifati-Hayek J; Bryan J; Banerjee S; Sobol I; Lachs MS; Safford MM; Goyal P
BMC Cardiovasc Disord; 2019 Apr; 19(1):76. PubMed ID: 30935411
[TBL] [Abstract][Full Text] [Related]
12. The association of degree of polypharmacy before and after among hospitalised internal medicine patients and clinical outcomes: a retrospective, population-based cohort study.
Jonsdottir F; Blondal AB; Gudmundsson A; Bates I; Stevenson JM; Sigurdsson MI
BMJ Open; 2024 Mar; 14(3):e078890. PubMed ID: 38548367
[TBL] [Abstract][Full Text] [Related]
13. Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study.
Kragh Ekstam A; Elmståhl S
Clin Interv Aging; 2016; 11():489-96. PubMed ID: 27199553
[TBL] [Abstract][Full Text] [Related]
14. Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis.
Chang CH; Lin JW; Chiu FC; Caffrey JL; Wu LC; Lai MS
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):76-82. PubMed ID: 24446025
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Bhagavathula AS; Tesfaye W; Vidyasagar K; Fialova D
Gerontology; 2022; 68(10):1081-1090. PubMed ID: 35026767
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy occurrence and the related risk of premature death among older adults in Denmark: A nationwide register-based cohort study.
Jørring Pallesen AV; Kristiansen M; Westendorp RGJ; Mortensen LH
PLoS One; 2022; 17(2):e0264332. PubMed ID: 35196345
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden.
Haider SI; Johnell K; Thorslund M; Fastbom J
Clin Ther; 2008 Feb; 30(2):419-27. PubMed ID: 18343279
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy Is Associated With Slow Gait Speed and Recurrent Falls in Older People With HIV.
Kosana P; Wu K; Tassiopoulos K; Letendre S; Ma Q; Paul R; Ellis R; Erlandson KM; Farhadian SF
Clin Infect Dis; 2024 Jun; 78(6):1608-1616. PubMed ID: 38147306
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy status as an indicator of mortality in an elderly population.
Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
Drugs Aging; 2009; 26(12):1039-48. PubMed ID: 19929031
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
